Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Caelyx maintenance in metastatic breast cancer
NCT00128778Phase 4Completed
- Sponsor
- GEICAM
- Start
- Oct 2002
- Primary completion
- Jun 2007
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in breast cancer comparing Arm A: PLD with Arm B: Observation (2 arms). Primary endpoint: Time to progression. Started Oct 2002; status: completed.
02
Drugs
pegylated liposomal doxorubicin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00128778.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00128778.